NCT02326857View on ClinicalTrials.gov

Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment

CompletedOBSERVATIONAL
Enrollment

1,334

Participants

Timeline

Start Date

December 23, 2014

Primary Completion Date

December 23, 2014

Study Completion Date

September 23, 2020

Conditions
Breast Cancer
Trial Locations (9)

Unknown

Instituto Leloir, Buenos Aires

Instituto Nacional de Cancer (INCA), Rio de Janeiro

Instituto do C(SqrRoot) ncer do Estado de S(SqrRoot) o Paulo, São Paulo

Instituto de Salud Publica, Santiago

Instituto Jalisciense de Cancerologia, Guadalajara

Universidad de Guadalajara, Guadalajara

Universidad de Sonora, Sonora

Institito Nacional de C(SqrRoot)(Degree)ncer, Montevideo

Instituto Pasteur de Montevideo, Montevideo

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT02326857 - Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment | Biotech Hunter | Biotech Hunter